ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea · Delayed Price · Currency is KRW 52,300
-2,400 (-4.39%)
At close: Feb 6, 2026
ROKIT Healthcare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 20,328 | 13,111 | 12,418 | 9,151 | 6,741 | 3,990 |
Other Revenue | - | -0 | -0 | -0 | - | - |
| 20,328 | 13,111 | 12,418 | 9,151 | 6,741 | 3,990 | |
Revenue Growth (YoY) | 54.62% | 5.59% | 35.70% | 35.76% | 68.94% | -60.85% |
Cost of Revenue | 7,824 | 7,147 | 8,391 | 6,087 | 5,126 | 4,391 |
Gross Profit | 12,504 | 5,964 | 4,026 | 3,064 | 1,615 | -400.65 |
Selling, General & Admin | 11,588 | 8,217 | 8,353 | 12,747 | 13,661 | 9,151 |
Research & Development | 1,132 | 1,571 | 1,772 | 2,979 | 3,825 | 2,902 |
Amortization of Goodwill & Intangibles | 308.97 | 304.26 | 465.35 | 433.47 | 448.22 | 518.44 |
Other Operating Expenses | 36.06 | 31.03 | 46.03 | 46 | 51.68 | 25.11 |
Operating Expenses | 15,106 | 12,006 | 11,594 | 16,938 | 18,935 | 16,770 |
Operating Income | -2,602 | -6,042 | -7,568 | -13,873 | -17,320 | -17,171 |
Interest Expense | -7,137 | -6,845 | -6,209 | -4,503 | -3,290 | -2,618 |
Interest & Investment Income | 172.04 | 51.64 | 50.57 | 30.08 | 29.52 | 55.14 |
Currency Exchange Gain (Loss) | -135.54 | -53.56 | 19.13 | 21.99 | 285.9 | -164.89 |
Other Non Operating Income (Expenses) | 3,402 | 5,533 | 31,218 | 20,353 | -35,526 | -14,362 |
EBT Excluding Unusual Items | -6,301 | -7,356 | 17,511 | 2,029 | -55,820 | -34,261 |
Gain (Loss) on Sale of Assets | -1.95 | 0.99 | -2.29 | -1.8 | 0.36 | -1.57 |
Asset Writedown | -9.39 | 18.28 | -687.74 | - | -464.33 | -1,075 |
Other Unusual Items | - | - | 10.11 | - | - | - |
Pretax Income | -6,312 | -7,337 | 16,831 | 2,027 | -56,284 | -35,338 |
Income Tax Expense | 1,053 | 352.74 | 204.02 | 169.59 | 108.86 | 28.63 |
Earnings From Continuing Operations | -7,366 | -7,690 | 16,627 | 1,857 | -56,393 | -35,366 |
Minority Interest in Earnings | 32.63 | 44.34 | -27.17 | 17.39 | 145.59 | 138.49 |
Net Income | -7,333 | -7,646 | 16,600 | 1,875 | -56,247 | -35,228 |
Net Income to Common | -7,333 | -7,646 | 16,600 | 1,875 | -56,247 | -35,228 |
Net Income Growth | - | - | 785.55% | - | - | - |
Shares Outstanding (Basic) | 11 | 8 | 7 | 7 | 7 | 6 |
Shares Outstanding (Diluted) | 11 | 8 | 12 | 12 | 7 | 6 |
Shares Change (YoY) | -11.41% | -34.20% | 0.64% | 72.42% | 6.78% | 0.93% |
EPS (Basic) | -669.94 | -978.30 | 2324.34 | 267.01 | -8217.71 | -5495.87 |
EPS (Diluted) | -669.94 | -978.30 | -829.59 | -1232.84 | -8218.00 | -5495.87 |
Free Cash Flow | -11,783 | -5,023 | -4,065 | -6,777 | -12,121 | -8,317 |
Free Cash Flow Per Share | -1076.49 | -642.68 | -342.24 | -574.26 | -1770.81 | -1297.60 |
Gross Margin | 61.51% | 45.49% | 32.42% | 33.49% | 23.96% | -10.04% |
Operating Margin | -12.80% | -46.09% | -60.94% | -151.61% | -256.95% | -430.36% |
Profit Margin | -36.07% | -58.31% | 133.68% | 20.48% | -834.44% | -882.92% |
Free Cash Flow Margin | -57.96% | -38.31% | -32.73% | -74.06% | -179.81% | -208.46% |
EBITDA | -1,785 | -5,054 | -6,300 | -12,498 | -15,712 | -15,722 |
EBITDA Margin | -8.78% | -38.55% | -50.73% | -136.57% | -233.08% | - |
D&A For EBITDA | 817.31 | 987.8 | 1,267 | 1,376 | 1,609 | 1,449 |
EBIT | -2,602 | -6,042 | -7,568 | -13,873 | -17,320 | -17,171 |
EBIT Margin | -12.80% | -46.08% | -60.94% | -151.61% | -256.95% | - |
Effective Tax Rate | - | - | 1.21% | 8.37% | - | - |
Advertising Expenses | - | 430.02 | 303.4 | 752.62 | 647.84 | 711.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.